130 related articles for article (PubMed ID: 31625062)
1. Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats.
Kolik LG; Nadorova AV; Antipova TA; Kruglov SV; Kudrin VS; Durnev AD
Bull Exp Biol Med; 2019 Sep; 167(5):641-644. PubMed ID: 31625062
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of peptide anxiolytic selank during modeling of withdrawal syndrome in rats with stable alcoholic motivation.
Kolik LG; Nadorova AV; Kozlovskaya MM
Bull Exp Biol Med; 2014 May; 157(1):52-5. PubMed ID: 24913576
[TBL] [Abstract][Full Text] [Related]
3. Involvement of hippocampal agmatine in β
Kotagale N; Rahmatkar S; Chauragade S; Dixit M; Umekar M; Chopde C; Taksande B
Neurotoxicology; 2020 Sep; 80():1-11. PubMed ID: 32522471
[TBL] [Abstract][Full Text] [Related]
4. Effect of metformin treatment on memory and hippocampal neurogenesis decline correlated with oxidative stress induced by methotrexate in rats.
Sritawan N; Suwannakot K; Naewla S; Chaisawang P; Aranarochana A; Sirichoat A; Pannangrong W; Wigmore P; Welbat JU
Biomed Pharmacother; 2021 Dec; 144():112280. PubMed ID: 34628167
[TBL] [Abstract][Full Text] [Related]
5. [Changes in expression of the genes for chemokines, cytokines, and their receptors in response to selank and its fragments].
Kolomin TA; Shadrina MI; Slominskiĭ PA; Limborskaia S; Miasoedov NF
Genetika; 2011 May; 47(5):711-4. PubMed ID: 21786679
[TBL] [Abstract][Full Text] [Related]
6. Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the hippocampus and prefrontal cortex.
Di Liberto V; Frinchi M; Verdi V; Vitale A; Plescia F; Cannizzaro C; Massenti MF; Belluardo N; Mudò G
Psychopharmacology (Berl); 2017 Feb; 234(4):559-573. PubMed ID: 27957715
[TBL] [Abstract][Full Text] [Related]
7. Alcohol-induced cognitive deficits are associated with decreased circulating levels of the neurotrophin BDNF in humans and rats.
Silva-Peña D; García-Marchena N; Alén F; Araos P; Rivera P; Vargas A; García-Fernández MI; Martín-Velasco AI; Villanúa MÁ; Castilla-Ortega E; Santín L; Pavón FJ; Serrano A; Rubio G; Rodríguez de Fonseca F; Suárez J
Addict Biol; 2019 Sep; 24(5):1019-1033. PubMed ID: 30277635
[TBL] [Abstract][Full Text] [Related]
8. Alcohol dependence-induced regulation of the proliferation and survival of adult brain progenitors is associated with altered BDNF-TrkB signaling.
Somkuwar SS; Fannon MJ; Staples MC; Zamora-Martinez ER; Navarro AI; Kim A; Quigley JA; Edwards S; Mandyam CD
Brain Struct Funct; 2016 Dec; 221(9):4319-4335. PubMed ID: 26659122
[TBL] [Abstract][Full Text] [Related]
9. Intranasal administration of the peptide Selank regulates BDNF expression in the rat hippocampus in vivo.
Inozemtseva LS; Karpenko EA; Dolotov OV; Levitskaya NG; Kamensky AA; Andreeva LA; Grivennikov IA
Dokl Biol Sci; 2008; 421():241-3. PubMed ID: 18841804
[No Abstract] [Full Text] [Related]
10. Repeated diazepam administration reversed working memory impairments and glucocorticoid alterations in the prefrontal cortex after short but not long alcohol-withdrawal periods.
Dominguez G; Henkous N; Pierard C; Belzung C; Mons N; Beracochea D
Cogn Affect Behav Neurosci; 2018 Aug; 18(4):665-679. PubMed ID: 29713956
[TBL] [Abstract][Full Text] [Related]
11. Corticosterone protects against memory impairments and reduced hippocampal BDNF levels induced by a chronic low dose of ethanol in C57BL/6J mice.
Ebada ME; Latif LM; Kendall DA; Pardon MC
Rom J Morphol Embryol; 2014; 55(4):1303-16. PubMed ID: 25611260
[TBL] [Abstract][Full Text] [Related]
12.
Ravichandran VA; Kim M; Han SK; Cha YS
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30018265
[TBL] [Abstract][Full Text] [Related]
13. [Experimental optimization of learning and memory processes by selank].
Semenova TP; Kozlovskiĭ II; Zakharova NM; Kozlovskaia MM
Eksp Klin Farmakol; 2010 Aug; 73(8):2-5. PubMed ID: 20919548
[TBL] [Abstract][Full Text] [Related]
14. Short-term memory impairment and reduced hippocampal c-Fos expression in an animal model of fetal alcohol syndrome.
Clements KM; Girard TA; Ellard CG; Wainwright PE
Alcohol Clin Exp Res; 2005 Jun; 29(6):1049-59. PubMed ID: 15976532
[TBL] [Abstract][Full Text] [Related]
15. Taurine restores the exploratory behavior following alcohol withdrawal and decreases BDNF mRNA expression in the frontal cortex of chronic alcohol-treated rats.
Hansen AW; Almeida FB; Bandiera S; Pulcinelli RR; Fragoso ALR; Schneider R; Barros HMT; Gomez R
Pharmacol Biochem Behav; 2017 Oct; 161():6-12. PubMed ID: 28882570
[TBL] [Abstract][Full Text] [Related]
16. Functional Connectomic Approach to Studying Selank and Semax Effects.
Panikratova YR; Lebedeva IS; Sokolov OY; Rumshiskaya AD; Kupriyanov DA; Kost NV; Myasoedov NF
Dokl Biol Sci; 2020 Jan; 490(1):9-11. PubMed ID: 32342318
[TBL] [Abstract][Full Text] [Related]
17. Effects of the Positive Allosteric Modulator of Metabotropic Glutamate Receptor 5, VU-29, on Impairment of Novel Object Recognition Induced by Acute Ethanol and Ethanol Withdrawal in Rats.
Marszalek-Grabska M; Gibula-Bruzda E; Bodzon-Kulakowska A; Suder P; Gawel K; Filarowska J; Listos J; Danysz W; Kotlinska JH
Neurotox Res; 2018 Apr; 33(3):607-620. PubMed ID: 29294238
[TBL] [Abstract][Full Text] [Related]
18. Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity.
Vyunova TV; Andreeva L; Shevchenko K; Myasoedov N
Protein Pept Lett; 2018; 25(10):914-923. PubMed ID: 30255741
[TBL] [Abstract][Full Text] [Related]
19. Long-lasting recognition memory impairment and alterations in brain levels of cytokines and BDNF induced by maternal deprivation: effects of valproic acid and topiramate.
Pinheiro RM; de Lima MN; Portal BC; Busato SB; Falavigna L; Ferreira RD; Paz AC; de Aguiar BW; Kapczinski F; Schröder N
J Neural Transm (Vienna); 2015 May; 122(5):709-19. PubMed ID: 25182413
[TBL] [Abstract][Full Text] [Related]
20. Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment.
Lu P; Mamiya T; Lu L; Mouri A; Niwa M; Kim HC; Zou LB; Nagai T; Yamada K; Ikejima T; Nabeshima T
Behav Brain Res; 2010 Mar; 207(2):387-93. PubMed ID: 19857526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
